Carregando...

Prolonged Subcutaneous Administration of 852A, a Novel Systemic Toll-like Receptor 7 Agonist, to Activate Innate Immune Responses in Patients with Advanced Hematologic Malignancies

The toll-like receptor (TLR) 7 agonist 852A, a small-molecule imidazoquinoline, stimulates plasmacytoid dendritic cells to produce multiple cytokines. We conducted a Phase II study of 852A in patients with recurrent hematologic malignancies. The primary objective was assessing the activity of 852A a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Weigel, Brenda J., Cooley, Sarah, DeFor, Todd, Weisdorf, Daniel J., Panoskaltsis-Mortari, Angela, Chen, Wei, Blazar, Bruce R., Miller, Jeffrey S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3638918/
https://ncbi.nlm.nih.gov/pubmed/22718533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23280
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!